Skip to main content

Day: June 29, 2023

Rakovina Therapeutics Announces Results from 2023 Annual General Meeting

Written by Customer Service on . Posted in Public Companies.

VANCOUVER, British Columbia, June 28, 2023 (GLOBE NEWSWIRE) — Rakovina Therapeutics Inc. (TSXV: RKV) (the “Company”), a biopharmaceutical company committed to advancing new cancer therapies based on novel DNA-damage response technologies, is pleased to announce the results of voting at its 2023 annual general meeting of shareholders held on June 28, 2023 (the “Meeting”). All four members of the Company’s board of directors named as nominees in its management information circular (the “Circular”) were re-elected as directors: Jeffrey Bacha, Dr. Dennis Brown, Alfredo De Lucrezia and Michael Liggett. Additional voting results from the Meeting include: (i) the shareholders approved the appointment of Davidson & Company LLP as the Company’s auditor until the next annual meeting; and (ii) the shareholders approved the Company’s...

Continue reading

Digital Shipyard Market to Surpass 5.5 Billion by 2030 Drives Due to the Rising Demand for Efficient and Advanced Vessels

Written by Customer Service on . Posted in Mergers And Acquisitions.

SkyQuest projects that the digital shipyard market will attain a USD 5.5 billion value by 2030, with a CAGR of 19.1% over the forecast period (2023-2030). The global digital shipyard market is poised to experience substantial growth in the forecast period, primarily driven by the escalating international seaborne trade. The demand for efficient and advanced vessels has significantly increased with the continuous expansion of global business. Westford, USA, June 28, 2023 (GLOBE NEWSWIRE) — According to SkyQuest, the digital shipyard market is witnessing significant growth owing to several factors. Firstly, the rising use of cloud-based maintenance systems has gained momentum as sea trade expands. Shipyards are increasingly adopting cloud-based systems to streamline maintenance processes, enhance operational efficiency, and ensure...

Continue reading

Fabiotech Announces Acquisition of Shares of Royal Standard Minerals Inc.

Written by Customer Service on . Posted in Mergers And Acquisitions.

TORONTO, June 28, 2023 (GLOBE NEWSWIRE) — Fabiotech Inc. (the “Corporation”) announces that it has filed an early warning report in respect of the acquisition of shares of Royal Standard Minerals Inc. (unlisted) (“Royal Standard”). On June 28, 2023, the Corporation entered into a purchase agreement with an arm’s length third party pursuant to which the Corporation purchased an aggregate of 504,449 common shares of Royal Standard (the “Royal Standard Shares”) aggregate consideration of $10,000 (approximately $0.0198 per share) (the “Acquisition”). Immediately prior to giving effect to the Acquisition, the Corporation had beneficial ownership of, or control and direction over, no Royal Standard Shares. Immediately after giving effect to the Acquisition, the Corporation had beneficial ownership of, or control and direction over, 504,449...

Continue reading

Fabiotech Announces Acquisition of Shares of OutdoorPartner Media Corporation

Written by Customer Service on . Posted in Mergers And Acquisitions.

TORONTO, June 28, 2023 (GLOBE NEWSWIRE) — Fabiotech Inc. (the “Corporation”) announces that it has filed an early warning report in respect of the acquisition of shares of OutdoorPartner Media Corporation (unlisted) (“OutdoorPartner”). On June 28, 2023, the Corporation entered into a purchase agreement with an arm’s length third party pursuant to which the Corporation purchased an aggregate of 28,778,204 common shares of OutdoorPartner (the “OutdoorPartner Shares”) for aggregate consideration of $5,000 (approximately $0.000174 per share (the “Acquisition”). Immediately prior to giving effect to the Acquisition, the Corporation had beneficial ownership of, or control and direction over, no OutdoorPartner Shares. Immediately after giving effect to the Acquisition, the Corporation had beneficial ownership of, or control and direction...

Continue reading

Weebit Nano’s ReRAM IP now fully qualified in SkyWater Technology’s S130 process

Written by Customer Service on . Posted in Public Companies.

Achievement attests to quality, reliability and repeatability of Weebit’s embedded IP for use in customer production chips HOD HASHARON, Israel and BLOOMINGTON, Minn., June 28, 2023 (GLOBE NEWSWIRE) — Weebit Nano Limited (ASX:WBT), a leading developer of advanced memory technologies for the global semiconductor industry, and SkyWater Technology (NASDAQ: SKYT), the trusted technology realization partner, confirm Weebit Resistive Random-Access Memory (ReRAM) IP has been fully qualified for industrial temperatures employing SkyWater’s 130nm CMOS (S130) process, including third party processing. The full qualification confirms the quality, repeatability and reliability of Weebit’s embedded ReRAM module, when SkyWater customers use Weebit’s proven non-volatile memory (NVM) IP in volume production. The qualification used demo chips produced...

Continue reading

Ipsen announces positive outcome of FDA Advisory Committee on investigational palovarotene for fibrodysplasia ossificans progressiva

Written by Customer Service on . Posted in Public Companies.

Advisory committee voted 10 for and 4 against that evidence from the Phase III MOVE study show palovarotene is an effective treatment in patients with the ultra-rare bone disease fibrodysplasia ossificans progressiva (FOP) Advisory committee further voted 11 for and 3 against on the benefits of palovarotene outweighing the risks, for the treatment of patients with FOP FDA PDUFA action date is anticipated by August 16, 2023PARIS, FRANCE, 29 June 2023 – Ipsen (Euronext: IPN; ADR: IPSEY) announced today that the U.S. Food and Drug Administration’s (FDA) Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC) voted in favor of investigational palovarotene as an effective treatment, with a positive risk-benefit profile, for people living with the ultra-rare bone disease, fibrodysplasia ossificans progressiva (FOP). The FDA is currently...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.